Despite major advancements, the optimal treatment for Kaposi sarcoma has yet to be defined. Comparable standards employing existing therapies to satisfactorily manage all epidemiologic forms of Kaposi sarcoma, and the utilization of mechanism‐based therapeutic strategies with innovative surrogate endpoints to appraise their efficacy, are required.